Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 14/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 8/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | DRD4 | P21917 | 3/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.45 |
| ▸ | HRH1 | P35367 | 2/20 | 0.45 |
| ▸ | HTR2B | P41595 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6877476 | 1.00 | MCHR1 (0.52) | MCHR1ADRA2AKMT2ADRD4ADRA1A | |
| SCHEMBL6867804 | 0.95 | MCHR1 (0.49) | MCHR1ADRA2AKMT2ADRD4ADRA1A | |
| SCHEMBL6867807 | 0.95 | MCHR1 (0.49) | MCHR1ADRA2AKMT2ADRD4ADRA1A | |
| SCHEMBL6462473 | 0.87 | MCHR1 (0.45) | MCHR1ADRA2AKMT2AHRH1HTR2B | |
| SCHEMBL6462469 | 0.87 | MCHR1 (0.45) | MCHR1ADRA2AKMT2AHRH1HTR2B | |
| SCHEMBL6874497 | 0.85 | MCHR1 (0.48) | MCHR1ADRA2AADRA1AHRH1HTR2B | |
| SCHEMBL6874502 | 0.85 | MCHR1 (0.48) | MCHR1ADRA2AADRA1AHRH1HTR2B | |
| SCHEMBL6873378 | 0.84 | GAA (0.54) | MCHR1ADRA2AKMT2AADRA1AHRH1 | |
| SCHEMBL6873370 | 0.84 | GAA (0.54) | MCHR1ADRA2AKMT2AADRA1AHRH1 | |
| SCHEMBL6878280 | 0.84 | MCHR1 (0.46) | MCHR1ADRA2AADRA1AHRH1HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1464335-A2 | Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist | Taisho Pharmaceutical Co. Ltd. (JP) | 2004-10-06 | — | — | EP | disclosed |